Loading clinical trials...
Loading clinical trials...
PRIMA-HF PRedicting Recovery of Left Ventricular Function With Multimodality Cardiac IMAging in Patients With de Novo Heart Failure HAI-HF: High-Dose Adenosine During Perfusion Imaging in Heart Failure: Rationale and Design of the HAI-HF Trial
Conditions
Interventions
HAI-HF: Adenosine Stress [¹⁵O]H₂O PET Imaging
Two different doses of adenosine
Locations
1
Denmark
University Clinic of Cardiovascular Reseach
Herning, Denmark
Start Date
December 8, 2025
Primary Completion Date
April 30, 2029
Completion Date
April 30, 2029
Last Updated
December 26, 2025
NCT07083011
NCT07550790
NCT07037459
NCT06148935
NCT06874556
NCT06741436
Lead Sponsor
Gødstrup Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions